Clinician-guided GLP-1 protocols matched to your body, your history, and your goal - shipped cold-packed from licensed US pharmacies.
PinwellRx offers clinician-guided weight-loss care online: compounded semaglutide and tirzepatide, in weekly injection or daily tablet form prepared by licensed U.S. pharmacies. Compounded medications are not FDA-approved. A licensed clinician reviews your intake and prescribes only when appropriate. You see your price before you pay.
Sources: FDA prescribing information, peer-reviewed clinical trials and NIH literature · Updated August 2026
Takes about 10 minutes · a clinician can decline · full refund if not prescribed
~21%
Average body-weight reduction
That is what participants averaged in SURMOUNT-1, the pivotal 72-week trial of Zepbound® (tirzepatide), alongside lifestyle support - roughly one-fifth of body weight, in the largest study of the strongest approved molecule in weight medicine.
Versus about 3% with lifestyle support alone. Trial studied the FDA-approved brand-name product, not compounded preparations. Individual results vary and are not guaranteed; a licensed clinician decides what is appropriate for you.
This page is general health information, not medical advice. It cannot diagnose you or tell you what treatment is right for you. Only a licensed clinician who has reviewed your history can do that, and they may decide treatment is not appropriate. Individual results vary and no outcome is guaranteed.
What the first twelve weeks tend to look like
Titration is deliberate. The appetite signal builds as the dose steps up, which is why week one rarely feels like much and week eight often does.
Week 1 to 4
Doses start low by design. This stretch is about tolerability rather than results, and most people feel little at first.
Week 4 to 8
As the dose steps up, most people notice meals ending sooner and cravings losing their edge.
Week 9 and beyond
The routine settles. Protein and resistance training are what protect muscle while weight comes off, and your clinician keeps adjusting to your response.
In SURMOUNT-1, the pivotal 72-week trial of Zepbound® (tirzepatide), participants averaged about 21% body-weight reduction alongside lifestyle support, versus about 3% with lifestyle support alone. In STEP 1, Wegovy® (semaglutide) averaged about 15% over 68 weeks. Those trials studied the FDA-approved brand-name products, not compounded preparations. Typical patterns under clinician supervision, not a guarantee. Individual results vary, compounded medications are not FDA-approved, and a licensed clinician decides what is appropriate for you.
Your options
A licensed clinician makes the final recommendation and prescribing decision.
Oral tabletsSwallowed once a day - no needles, no cold chain
Compounded
Oral Semaglutide
Compounded tablet
Semaglutide’s fullness pathway - stomach slows, meals end sooner - as a compounded daily tablet for people who would rather never inject. Prepared against your prescription; compounded medications are not FDA-approved.
Weekly injectionsA small once-weekly shot you give yourself at home
Compounded
Compounded Tirzepatide
Weekly injection
The molecule that changed the conversation: two gut-hormone receptors at once, so fullness arrives sooner and stays longer. Trials of the approved products in this class averaged ~21% body-weight reduction over 72 weeks - individual results vary, and compounded preparations are not FDA-approved.
The molecule that rewrote weight medicine: it mimics GLP-1, the fullness hormone your gut already makes, so the stomach slows and appetite goes quiet. Approved medicines in this class averaged ~15% weight loss in landmark trials - individual results vary, and compounded preparations are not FDA-approved.
Trial results and label statements belong to the cited FDA-approved products and publications - they are not claims about compounded medications. Compounded medications are not FDA-approved.
Skip to main content
